How Trasis develops GMP-Grade radiopharmaceutical ingredients from early chemistry to clinical use скачать в хорошем качестве

How Trasis develops GMP-Grade radiopharmaceutical ingredients from early chemistry to clinical use

Transforming a complex idea into a GMP-grade precursor ready for clinical studies involves demanding steps: chemical route design, automation, purification, production, fill & finish, and regulatory expectations. In this video, Antoine Briffaux and Victor-Emmanuel Kassin explain how Trasis supports these projects through an integrated setup combining development, GMP production, analytical work, and documentation. The Trivehexin case illustrates this approach, showing how sensitive peptides and copper-based chemistry can be converted into a stable and scalable GMP process suitable for phase I and beyond. Disclaimer: This video is provided for informational purposes only, may be amended without notice, carries no guarantee of accuracy or completeness, and may not be reproduced without Trasis’s permissio